Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02269293
Title Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

endometrial cancer

fallopian tube cancer

peritoneum cancer

ovarian cancer

ovarian carcinosarcoma

Therapies

Carboplatin + Paclitaxel + Selinexor

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Memoral Sloan Kettering Monmouth Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Westchester Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field